Margaritaville at Sea Cruise Line announces a partnership with multi-platinum selling, three-time GRAMMY award-winning, and ...
Initial results of a Phase 1 / 2 open label study of AT-02, the company’s lead pan-amyloid removal therapeutic candidate, in patients with AL amyloidosis will be presented at ASH.The presentation ...